FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11764211000001102: Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42788401000001110 Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62010901000001112 Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oromucosal gel en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Is a Lidocaine + Cetylpyridinium true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.gingival ontology form and route true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.oromucosal ontology form and route true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Gingival route true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oromucosal route true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has active ingredient Cetylpyridinium chloride false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Is a Product containing cetylpyridinium and lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has specific active ingredient Cetylpyridinium chloride true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has active ingredient Cetylpyridinium false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has manufactured dose form Oromucosal AND/OR gingival dosage form false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has dispensed dose form Conventional release oromucosal gel true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Has manufactured dose form Conventional release oromucosal gel false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Sore Mouth gel (The Boots Company Plc) Is a True Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Is pack of False Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has VMP True Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start